GSK PLC (GSK)
33.69
+0.34
(+1.02%)
USD |
NYSE |
Nov 21, 16:00
33.69
0.00 (0.00%)
After-Hours: 20:00
GSK Profit Margin (Quarterly): -0.72% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -0.72% |
June 30, 2024 | 14.88% |
March 31, 2024 | 14.21% |
December 31, 2023 | 4.35% |
September 30, 2023 | 17.97% |
June 30, 2023 | 22.62% |
March 31, 2023 | 21.44% |
December 31, 2022 | 20.27% |
September 30, 2022 | |
June 30, 2022 | 12.09% |
March 31, 2022 | 25.06% |
December 31, 2021 | 3.10% |
September 30, 2021 | 20.64% |
June 30, 2021 | 23.90% |
March 31, 2021 | 14.46% |
December 31, 2020 | -67.30% |
September 30, 2020 | 14.39% |
June 30, 2020 | 29.68% |
March 31, 2020 | 17.22% |
December 31, 2019 | 14.60% |
September 30, 2019 | 16.54% |
June 30, 2019 | 12.34% |
March 31, 2019 | 10.83% |
December 31, 2018 | 14.82% |
September 30, 2018 | 17.52% |
Date | Value |
---|---|
June 30, 2018 | 6.03% |
March 31, 2018 | 7.60% |
December 31, 2017 | -7.15% |
September 30, 2017 | 15.45% |
June 30, 2017 | -2.46% |
March 31, 2017 | 14.17% |
December 31, 2016 | 3.39% |
September 30, 2016 | 10.71% |
June 30, 2016 | -6.66% |
March 31, 2016 | 4.53% |
December 31, 2015 | -5.63% |
September 30, 2015 | 8.78% |
June 30, 2015 | 2.53% |
March 31, 2015 | |
December 31, 2014 | 16.70% |
September 30, 2014 | 7.10% |
June 30, 2014 | 11.76% |
March 31, 2014 | 11.90% |
December 31, 2013 | 35.64% |
September 30, 2013 | 14.88% |
June 30, 2013 | 15.79% |
March 31, 2013 | 14.85% |
December 31, 2012 | 12.47% |
September 30, 2012 | 16.93% |
June 30, 2012 | 19.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-67.30%
Minimum
Dec 2020
29.68%
Maximum
Jun 2020
11.73%
Average
14.88%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
AstraZeneca PLC | 10.53% |
Pfizer Inc | 25.22% |
Sanofi SA | 19.88% |
Moderna Inc | 0.70% |
Autolus Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 18.89% |
Return on Assets | 4.23% |
Return on Invested Capital | 8.08% |
Gross Profit Margin (Quarterly) | 70.08% |
Operating Margin (Quarterly) | 2.36% |
Return on Net Operating Assets | 5.47% |